| Literature DB >> 32021391 |
Toni T Kfoury1,2, Mouna Ben Rehouma2, Paul J Zetlaoui1, Dan Benhamou1, Jean Xavier Mazoit1,2.
Abstract
PURPOSE: Animal models of regional anaesthesia are useful for studying the effects of blocks and improve their efficacy. The aim of our experiments was to validate a multi-site paravertebral block in the rat.Entities:
Keywords: animal model; parietal block; rat
Year: 2020 PMID: 32021391 PMCID: PMC6955609 DOI: 10.2147/JPR.S213820
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1(A) Injection sites of carrageenan in the abdominal wall. Carrageenan or saline was injected at a point 1/3 from midline on the bisector of the angle formed by the intersection between the line joining the two anterior superior iliac crests (horizontal line, mark 3) and the linea Alba (mark 1). (B) Landmarks for the parietal abdominal nerve block; Spine, ribs and vertebrae (T5, T10, L1, L4 and S1) are marked with a pen.
Figure 2(A) Nerves (large clear arrows) emerging from the spine (large solid arrow). Nerves pass under the paravertebral muscles (thin solid arrows) before entering the abdominal wall between parietal muscles. (B) Blue dots show injection location for parietal abdominal nerve block injection. (C) Diffusion of indigo carmine dye solution after muscular dissection.
Figure 3(A) Mechanical pain threshold in the two groups after parietal nerve block. The bupivacaine group shows a significant increase in threshold as compared to the placebo group. Box plots are median, 10th, 25th, 75th and 90th percentile, dots are lower and upper range. *p=0.007 vs control. (B) c-Fos reactive nuclei 2 hrs after injury in the dorsal horn at the T9-T10 level in two representative animals (control group in the upper part and bupivacaine group in the lower part). (C) Number of c-Fos immunoreactive nuclei in the spinal cord measured at different metameric levels. c-Fos reactive nuclei were significantly less numerous in the bupivacaine group than in the control group from T5 to L3. *p<0.0001 bupivacaine group vs control group.